Sorry 48hr shelf life for cu64.
- Forums
- ASX - By Stock
- CU6
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.16%
!
$2.35

Ann: First patient imaged in Phase III AMPLIFY trial, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.35 |
Change
0.115(5.16%) |
Mkt cap ! $718.2M |
Open | High | Low | Value | Volume |
$2.30 | $2.37 | $2.21 | $4.157M | 1.810M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 7369 | $2.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.35 | 12338 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 16532 | 2.340 |
10 | 18994 | 2.330 |
10 | 24195 | 2.320 |
9 | 28125 | 2.310 |
7 | 29810 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.350 | 6121 | 8 |
2.360 | 24500 | 19 |
2.370 | 42408 | 18 |
2.380 | 39719 | 15 |
2.390 | 35526 | 11 |
Last trade - 12.32pm 17/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online